Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05422027 |
|---|---|
| Brief Title: | Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma |
| First Submitted : | June 13, 2022 |
| First Submitted that Met QC Criteria : | June 13, 2022 |
| First Posted : | June 16, 2022 |
| Last Update Submitted that Met QC Criteria : | February 23, 2023 |
| Last Update Posted : | February 27, 2023 |